This startup will leverage AI to analyze data from exceptional cancer survivors, identifying unique biological markers, lifestyle factors, and treatment responses that deviate from the norm. The goal is to uncover insights that can inform personalized treatment strategies and preventative measures for a broader patient population, moving beyond average outcomes to focus on resilience.